Apollomics (APLM) Common Equity (2020 - 2025)

Apollomics (APLM) has reported Common Equity for 6 consecutive years, with $3.2 million the latest figure, recorded in Q4 2025.

• Quarterly Common Equity fell 34.46% year-over-year to $3.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 million (down 34.46% YoY) and the FY2025 annual result came in at $3.2 million, down 34.46% from the prior year.
• Common Equity declined to $3.2 million in Q4 2025 per APLM's latest filing, from $4.4 million in the prior quarter.
• Over the last five years, Common Equity for APLM reached as high as $55.7 million in Q2 2023 and fell as low as -$448.1 million in Q4 2022.
• A 5-year average of -$82.6 million and a median of $4.4 million in 2025 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity plunged 110.52% — and 2023, when it jumped 126.21%.
• Year by year, Common Equity stood at -$212.9 million in 2021, then tumbled by 110.52% to -$448.1 million in 2022, then soared by 109.2% to $41.2 million in 2023, then plunged by 88.2% to $4.9 million in 2024, then sank by 34.46% to $3.2 million in 2025.
• According to Business Quant data, Common Equity over the past three periods registered $3.2 million, $4.4 million, and $4.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.